Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. We describe a case of DIC XFL caused by prostate cancer...
Saved in:
Main Authors: | Shawn Y. Ong, Josephine Taverna, Clint Jokerst, Thomas Enzler, Emad Hammode, Elisa Rogowitz, Myke R. Green, Hani M. Babiker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/212543 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study
by: Henrik Toft Sørensen, et al.
Published: (2022-07-01) -
Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma
by: Jeremy Chuang, et al.
Published: (2019-01-01) -
Disseminated Intravascular Coagulation and Malignancy: A Case Report and Literature Review
by: Sumit Sohal, et al.
Published: (2020-01-01) -
Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
by: M. J. Schultz, et al.
Published: (2012-01-01) -
Risk Factors and Predictive Model for Disseminated Intravascular Coagulation in Patients with Multiple Myeloma
by: Rong Bao MM, et al.
Published: (2025-02-01)